AI in Healthcare is Here. Governance Determines How It Performs in Practice.

Many healthcare leaders have moved past asking whether artificial intelligence (AI) belongs in their organizations. It’s already influencing clinical workflows, revenue cycle operations, and patient engagement. The potential is real, and so are the risks.

As AI use expands, the conversation is shifting from adoption to execution. The question is no longer whether to use AI, but how to do so responsibly and in ways that protect privacy, support clinicians, and improve patient outcomes.

The Stakes Are Higher in Healthcare

AI in healthcare differs from AI in retail or marketing. When an algorithm influences a clinical decision or flags a patient for follow-up, it can affect care. That raises expectations around oversight and accountability.

For example, a model that helps prioritize patients for follow-up after discharge can look effective in a pilot. But once it is scaled, leaders need to know whether it performs consistently across service lines and patient populations, how it fits into care management workflows, and who is accountable when results are unclear.  

Without clear guardrails, organizations may run into issues related to data privacy, opaque decision-making, or unintended bias. Even tools that perform well in testing can create friction once they are embedded in day-to-day workflows. Good governance isn’t about slowing teams down. It’s about avoiding preventable surprises and making better decisions earlier in the process.

What AI Governance Looks Like in Practice

AI governance doesn’t have to be complicated, but it does need to be intentional. It starts with ownership. Clear accountability for how AI tools are evaluated, approved, and monitored matters. The organizations doing this well bring clinical leaders, information technology (IT), compliance, and operations together, rather than treating AI as a standalone technology initiative. In practice, an effective AI governance program typically includes:

• Data quality and lineage: If the underlying data is unreliable or poorly understood, results will be too.
• Transparency for end users: Clinicians don’t need to understand every line of code, but they should know what a tool is designed to do, what data it uses, and where it tends to struggle.
• Bias and equity monitoring: Models can reinforce disparities if no one is looking for them.
• Ongoing performance monitoring: AI is not a “set it and forget it” investment. Models change, data evolves, and performance can drift, so governance should include regular check-ins to confirm tools are still performing as intended. 

Enabling Innovation, Not Blocking It

A common concern I hear is that governance will slow teams down. Often, the opposite happens. When organizations put structure around how AI is reviewed and deployed, it reduces uncertainty. Teams know the process, understand expectations, and can move forward with more confidence. It can also build trust with clinicians and, over time, with patients. The organizations that struggle most are usually the ones trying to retrofit governance after AI is already widespread, which is a much harder path.

Leadership Sets the Tone

This can’t be delegated entirely to IT or data science teams. Executive leadership and boards need to be involved, not in the technical details, but in setting priorities and expectations. Defining the problem is key. I like to call it falling in love with the problem. Don’t chase the newest tools. Ask: What problem are we trying to solve with AI? Where are we willing to take risks, and where are we not? How will we measure success? Those leadership questions shape what comes next, and they influence the value the organization may get from its AI investments.